Glucagon-like peptide-1 receptor agonists have begun to shift our understanding of type 2 diabetes and obesity management. Clinical development has three main strategies: traditional approaches, enhancement, and exploratory routes. Despite the shared mechanisms of action, these clinical approaches vary considerably in development strategy and trial design.
This infographic provides a breakdown of considerations that apply to each investigation approach.
